Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) for Chronic Insomnia :A Randomized Controlled Trial
1 other identifier
interventional
82
1 country
1
Brief Summary
This randomized, open, parallel controlled study aims to explore the clinical effectiveness of smartphone-based digital Cognitive behavioural therapy for insomnia(dCBT-I). Patients who diagnosed chronic insomnia disorder and proficient in using mobile phone intended to receive CBT-I. Participants will be random allocation into Group dCBT-I and Group Sleep Education. Primary outcome is the insomnia severity as measured using the Insomnia Severity Index (ISI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2021
CompletedFirst Posted
Study publicly available on registry
March 3, 2021
CompletedStudy Start
First participant enrolled
March 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 6, 2022
CompletedDecember 7, 2022
December 1, 2022
10 months
February 28, 2021
December 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity Index (ISI)
The ISI is a 6-item self-report measure of impairment in daytime functioning due to inadequate sleep. The ISI shows adequate internal consistency, appropriate test-retest reliability, and sensitivity to change with treatment. Scores can range from 0 to 28, with higher scores indicating more impairment. Scores higher than 14 are thought to be indicative of the presence of clinical insomnia and change in scores of 8.4 have been found to reflect moderate improvement in clinical samples.
V2 and V4 visit ( 6, 18 weeks after recruitment).
Secondary Outcomes (9)
Sleep characters recorded by online sleep diary
baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.
Sleep characters recorded by smart bracelet
baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.
Dysfunctional Beliefs and Attitudes about sleep scale (DBAS-16)
baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.
Fatigue Severity Scale(FSS)
baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.
Health-related Quality of Life (SF-12)
baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.
- +4 more secondary outcomes
Study Arms (2)
Group of dCBT-I
EXPERIMENTALparticipants will receive 6-week smartphone-based dCBT-I from a Wechat applet
Group of sleep education
SHAM COMPARATORPatients will receive sleep health education like the advices getting from common sleep clinic by the same applet as the group of CBT-I in smartphone
Interventions
Participants will receive 6-week smartphone-based dCBT-I from a Wechat applet.
Participants will receive sleep education like the advices getting from common sleep clinic.
Eligibility Criteria
You may qualify if:
- Age≥18y;
- Participants who meet proposed ICSD-3 and DSM-5 criterias for persistent Insomnia Disorder. (a) a current complaint of poor sleep (diffculty initiating and/or maintaining sleep, early morning wakening, or non-restorative sleep); with (b) signifcant daytime effects in 1 of 6 domains (fatigue, daytime sleepiness, cognitive impairment \[e.g., concentration problems\], mood disturbance, impaired occupational or academic functioning \[e.g., poor productivity\], impaired interpersonal/ social functioning); and (c) affecting them 3 nights per week for 3 months.
- Insomnia Severity Index (ISI) ≥14;
- If a comorbid sleep or psychiatric disorder is present, treatment of this condition should be stable at the time of entry in the study. There is no requirement of insomnia medications.
- Can use APP/ Wechat applet skillfully, can freely communicate, read and fill the electronic questionnaire, well understanding.
- Sign informed consent
You may not qualify if:
- The presence of shift work, head injury, acute suicidality, current mania, schizophrenia or elevated substance use.
- With documented severe physical diseases impairing sleep: such as craniocerebral disease, cancer pain, unstable angina or uncontrolled heart failure, etc.
- Current or past CBT-I
- Epworth Sleepiness Scale (ESS) ≥12
- Without informed consent or not signed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Related Publications (1)
Zhang C, Liu Y, Guo X, Liu Y, Shen Y, Ma J. Digital Cognitive Behavioral Therapy for Insomnia Using a Smartphone Application in China: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2023 Mar 1;6(3):e234866. doi: 10.1001/jamanetworkopen.2023.4866.
PMID: 36972049DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jing Ma, Doctor
Peking University First Hospital
- STUDY DIRECTOR
Cheng Zhang, Doctor
Peking University First Hospital
- STUDY DIRECTOR
Yanan Liu, Doctor
Peking University First Hospital
- STUDY DIRECTOR
Yane Shen, Postgraduate
Peking University First Hospital
- STUDY DIRECTOR
Xiaoming Guo, Doctor
Peking University First Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
February 28, 2021
First Posted
March 3, 2021
Study Start
March 24, 2021
Primary Completion
January 6, 2022
Study Completion
July 6, 2022
Last Updated
December 7, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share